Global Antibody Production Market Size study, By Process (Upstream Processing, Downstream Processing, Filtration), By End-Users (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories, Research Institutes), and Regional Forecasts 2022-2028
- BIZ4950717
- 200 Pages
- March 2022
- Diagnostic and Biotech
The antibody is commonly known as the immunoglobulin and a Y-shaped protein. The antibodies are produced by the plasma cells and used by the immune system to protect the individual’s body from intruders such as bacteria and viruses. The immune system generates antibodies to fight against antigens or foreign bodies that enter inside the body. Accordingly, antibody production is boosting the competence of the immune system to fight against pathogens and safeguards the individual's body. The growing adoption of targeted immunotherapy, rising incidences of diseases such as rheumatoid arthritis, cancer, and other chronic diseases, and growing investments for the R&D activities, coupled with the growth of the pharmaceutical and biotechnological industry are the chief factors that are surging the market demand across the globe. For instance, as per the American Cancer Society, in the United States there were approximately 1,735,350 new cancer cases diagnosed and 609,640 cancer deaths in 2018. Also, the amount is likely to increase and reach to 1.9 million new cancer cases diagnosed and 609,360 cancer deaths by 2022.
. Thereby, rising incidences of the target diseases are anticipated to fuel the market demand in the near future. However, the high costs of primary antibodies and cost constraints associated with the adoption of membrane filters impede the growth of the market over the forecast period of 2022-2028. Also, the increasing demand for protein therapeutics and the growing risk of infectious diseases is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Antibody Production market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the availability of government funding for medical research, regulatory approvals and authorization for use of monoclonal antibodies (MABs) , and the presence of the leading companies in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing prevalence of cancer, as well as the rising need for quality cancer treatment, would create lucrative growth prospects for the Antibody Production market across the Asia-Pacific region.
Major market players included in this report are:
GE Healthcare
Thermo Fisher Scientific, Inc.
Sartorius AG
Merck KGaA
Pall Corporation
Sigma-Aldrich Corporation
Eppendorf AG
Cellab GmbH
INTEGRA Biosciences AG
FiberCell Systems Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Process
Upstream Processing
Downstream Processing
Filtration
By End-Users
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Antibody Production Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Antibody Production Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Antibody Production Market, by Process, 2020-2028 (USD Billion)
1.2.3. Global Antibody Production Market, by End Users, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antibody Production Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antibody Production Market Dynamics
3.1. Antibody Production Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing adoption of targeted immunotherapy
3.1.1.2. Rising R&D investments by pharmaceutical & biotechnological companies
3.1.2. Market Challenges
3.1.2.1. High costs of primary antibodies
3.1.2.2. Cost constraints associated to the adoption of membrane filters
3.1.3. Market Opportunities
3.1.3.1. Increasing demand for protein therapeutics
3.1.3.2. Growing risk of infectious diseases
Chapter 4. Global Antibody Production Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Antibody Production Market, by Process
6.1. Market Snapshot
6.2. Global Antibody Production Market by Process, Performance - Potential Analysis
6.3. Global Antibody Production Market Estimates & Forecasts by Process 2019-2028 (USD Billion)
6.4. Antibody Production Market, Sub Segment Analysis
6.4.1. Upstream Processing
6.4.2. Downstream Processing
6.4.3. Filtration
Chapter 7. Global Antibody Production Market, by End Users
7.1. Market Snapshot
7.2. Global Antibody Production Market by End Users, Performance - Potential Analysis
7.3. Global Antibody Production Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
7.4. Antibody Production Market, Sub Segment Analysis
7.4.1. Pharmaceutical and Biotechnology Companies
7.4.2. Diagnostic Laboratories
7.4.3. Research Institutes
Chapter 8. Global Antibody Production Market, Regional Analysis
8.1. Antibody Production Market, Regional Market Snapshot
8.2. North America Antibody Production Market
8.2.1. U.S. Antibody Production Market
8.2.1.1. Process estimates & forecasts, 2019-2028
8.2.1.2. End Users estimates & forecasts, 2019-2028
8.2.2. Canada Antibody Production Market
8.3. Europe Antibody Production Market Snapshot
8.3.1. U.K. Antibody Production Market
8.3.2. Germany Antibody Production Market
8.3.3. France Antibody Production Market
8.3.4. Spain Antibody Production Market
8.3.5. Italy Antibody Production Market
8.3.6. Rest of Europe Antibody Production Market
8.4. Asia-Pacific Antibody Production Market Snapshot
8.4.1. China Antibody Production Market
8.4.2. India Antibody Production Market
8.4.3. Japan Antibody Production Market
8.4.4. Australia Antibody Production Market
8.4.5. South Korea Antibody Production Market
8.4.6. Rest of Asia Pacific Antibody Production Market
8.5. Latin America Antibody Production Market Snapshot
8.5.1. Brazil Antibody Production Market
8.5.2. Mexico Antibody Production Market
8.6. Rest of The World Antibody Production Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. GE Healthcare
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific, Inc.
9.2.3. Sartorius AG
9.2.4. Merck KGaA
9.2.5. Pall Corporation
9.2.6. Sigma-Aldrich Corporation
9.2.7. Eppendorf AG
9.2.8. Cellab GmbH
9.2.9. INTEGRA Biosciences AG
9.2.10. FiberCell Systems Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 1. Global Antibody Production Market, report scope
TABLE 2. Global Antibody Production Market estimates & forecasts by Region 2019-2028 (USD Billion)
TABLE 3. Global Antibody Production Market estimates & forecasts by Process 2019-2028 (USD Billion)
TABLE 4. Global Antibody Production Market estimates & forecasts by End Users 2019-2028 (USD Billion)
TABLE 5. Global Antibody Production Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 6. Global Antibody Production Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 7. Global Antibody Production Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 8. Global Antibody Production Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 9. Global Antibody Production Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 10. Global Antibody Production Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 11. Global Antibody Production Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 12. Global Antibody Production Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 13. Global Antibody Production Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 14. Global Antibody Production Market by region, estimates & forecasts, 2019-2028 (USD Billion)
TABLE 15. U.S. Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 16. U.S. Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 17. U.S. Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 18. Canada Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 19. Canada Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 20. Canada Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 21. UK Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 22. UK Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 23. UK Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 24. Germany Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 25. Germany Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 26. Germany Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 27. RoE Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 28. RoE Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 29. RoE Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 30. China Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 31. China Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 32. China Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 33. India Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 34. India Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 35. India Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 36. Japan Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 37. Japan Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 38. Japan Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 39. RoAPAC Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 40. RoAPAC Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 41. RoAPAC Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 42. Brazil Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 43. Brazil Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 44. Brazil Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 45. Mexico Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 46. Mexico Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 47. Mexico Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 48. RoLA Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 49. RoLA Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 50. RoLA Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 51. Row Antibody Production Market estimates & forecasts, 2019-2028 (USD Billion)
TABLE 52. Row Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 53. Row Antibody Production Market estimates & forecasts by segment 2019-2028 (USD Billion)
TABLE 54. List of secondary sources, used in the study of global Antibody Production Market
TABLE 55. List of primary sources, used in the study of global Antibody Production Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
